What is a stock summary page? Click here for an overview.
Business Description
Humanigen Inc
NAICS : 325412
SIC : 2834
ISIN : US4448631048
Compare
Compare
Traded in other countries / regions
HGENQ.USA0KB2.Germany Index Membership
Russell 2000 IPO Date
2013-01-31Description
Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. It has one segment, which is related to the development of pharmaceutical products.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.54 | |||||
| 9-Day RSI | 49.61 | |||||
| 14-Day RSI | 49.91 | |||||
| 6-1 Month Momentum % | 200 | |||||
| 12-1 Month Momentum % | -99.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -3785.46 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-Forward-EBIT | -0.04 | |||||
| EV-to-Forward-EBITDA | -0.04 | |||||
| EV-to-Forward-Revenue | 0.55 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HGENQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Humanigen Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.699 | ||
| EPS (TTM) ($) | -0.54 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -1.27 | ||
| 3-Year Sortino Ratio | -1.4 | ||
| Volatility % | 184.85 | ||
| 14-Day RSI | 49.91 | ||
| 14-Day ATR ($) | 0.000139 | ||
| 20-Day SMA ($) | 0.0002 | ||
| 12-1 Month Momentum % | -99.84 | ||
| 52-Week Range ($) | 0.00001 - 0.207 | ||
| Shares Outstanding (Mil) | 119.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Humanigen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Humanigen Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Humanigen Inc Frequently Asked Questions
What is Humanigen Inc(HGENQ)'s stock price today?
The current price of HGENQ is $0.00. The 52 week high of HGENQ is $0.21 and 52 week low is $0.00.
When is next earnings date of Humanigen Inc(HGENQ)?
The next earnings date of Humanigen Inc(HGENQ) is 2025-05-30 Est..
Does Humanigen Inc(HGENQ) pay dividends? If so, how much?
Humanigen Inc(HGENQ) does not pay dividend.
Guru Commentaries on OTCPK:HGENQ
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers